Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
A SPAC I Acquisition Unit | ASCAU | 5. jui 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | 5. jui 2024 | 11.16 | 0.00 |
A-Mark Precious Metals | AMRK | 5. jui 2024 | 35.48 | +0.70 |
a.k.a Brands | AKA | 5. jui 2024 | 16.13 | -1.44 |
A.O Smith | AOS | 5. jui 2024 | 82.08 | +1.02 |
A10 Networks | ATEN | 5. jui 2024 | 14.56 | +1.39 |
A2Z Smart Technologies | AZ | 5. jui 2024 | 0.38 | -3.70 |
AAA - A Rated Corporate Bond Ishares | QLTA | 5. jui 2024 | 47.16 | +0.28 |
Aadi Bioscience | AADI | 5. jui 2024 | 1.78 | +1.14 |
AAON | AAON | 5. jui 2024 | 73.47 | +2.04 |
AAR | AIR | 5. jui 2024 | 69.48 | +0.35 |
Abacus Life | ABL | 5. jui 2024 | 10.80 | -6.09 |
Abbott Laboratories | ABT | 5. jui 2024 | 103.23 | -0.19 |
AbbVie | ABBV | 5. jui 2024 | 165.44 | +2.04 |
AbCellera Biologics | ABCL | 5. jui 2024 | 3.75 | -0.79 |
Abeona Therapeutics | ABEO | 5. jui 2024 | 4.52 | +4.39 |
Abercrombie & Fitch | ANF | 5. jui 2024 | 172.70 | +1.80 |
Aberdeen Asia-Pacificome Fund | FAX | 5. jui 2024 | 2.66 | +0.38 |
Aberdeen Australia Equity Fund | IAF | 5. jui 2024 | 4.29 | +1.54 |
Aberdeen Emerging Markets Fund | AEF | 5. jui 2024 | 5.26 | +1.94 |
Aberdeen Global Fund | FCO | 5. jui 2024 | 5.66 | -0.53 |
Aberdeen Global Infrastructure | ASGI | 5. jui 2024 | 18.85 | -0.11 |
Aberdeen Income Credit Strategies Fund | ACP | 5. jui 2024 | 6.74 | 0.00 |
Aberdeen Income Credit Strategies Pref | ACP-A | 5. jui 2024 | 25.00 | 0.00 |
Aberdeen Japan Equity Fund | JEQ | 5. jui 2024 | 5.93 | -0.17 |
Abits Group | ABTS | 5. jui 2024 | 0.66 | +4.73 |
Abivax SA - American Depositary Shares | ABVX | 5. jui 2024 | 13.53 | +1.50 |
Able View Global | ABLV | 5. jui 2024 | 1.19 | +5.31 |
ABM Industries | ABM | 5. jui 2024 | 47.76 | +0.42 |
Abrdn Global Dynamic Dividend Fund | AGD | 5. jui 2024 | 9.74 | +1.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.